{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:45:00Z","timestamp":1791773100659,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030833","name":"Syneos Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2025.103296","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:30:13Z","timestamp":1765557013000},"page":"103296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of direct oral anticoagulants in patients with liver cirrhosis: a meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-6243","authenticated-orcid":false,"given":"Daniel","family":"Tham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayhan","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Sreeraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Eshaghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103296_bib1","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103296_bib2","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103296_bib3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpth.2025.103296_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1665-2681(19)31312-2","article-title":"Coagulation abnormalities in the cirrhotic patient","volume":"12","author":"Muci\u00f1o-Bermejo","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.rpth.2025.103296_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.rpth.2025.103296_bib6","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","article-title":"Oral anticoagulation in patients with liver disease","volume":"71","author":"Qamar","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103296_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2025.103296_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1060028019841582","article-title":"Direct oral anticoagulants in chronic liver disease","volume":"53","author":"Steuber","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2025.103296_bib9","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s12325-020-01307-z","article-title":"Direct oral anticoagulants in patients with liver disease in the era of non-alcoholic fatty liver disease global epidemic: a narrative review","volume":"37","author":"Ballestri","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.rpth.2025.103296_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103296_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103296_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103296_bib13","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103296_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ejh.13045","article-title":"Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation","volume":"100","author":"Goriacko","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.103296_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.103296_bib16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103296_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103296_bib18","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.rpth.2025.103296_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.rpth.2025.103296_bib20","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rpth.2025.103296_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.rpth.2025.103296_bib22","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103296_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103296_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103296_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/10600280211047433","article-title":"Safety and efficacy of direct oral anticoagulants in patients with moderate to severe cirrhosis","volume":"56","author":"Oldham","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2025.103296_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/10600280211025050","article-title":"Direct oral anticoagulants versus warfarin for treatment of thrombosis or atrial fibrillation in patients with cirrhosis: a retrospective cohort study","volume":"56","author":"Coons","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2025.103296_bib27","first-page":"479","article-title":"Retrospective review on the safety and efficacy of direct oral anticoagulants compared with warfarin in patients with cirrhosis","volume":"37","author":"Jones","year":"2020","journal-title":"Fed Pract"},{"key":"10.1016\/j.rpth.2025.103296_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.122.060687","article-title":"Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study","volume":"147","author":"Lawal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103296_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.rpth.2025.103296_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2019.02.003","article-title":"Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease","volume":"176","author":"Davis","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103296_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11239-019-02035-0","article-title":"Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes","volume":"50","author":"Davis","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2025.103296_bib32","doi-asserted-by":"crossref","first-page":"S-1469","DOI":"10.1016\/S0016-5085(20)34331-6","article-title":"Tu1719 direct acting oral anticoagulant use is safe and effective in patients with cirrhosis","volume":"158","author":"Hadi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpth.2025.103296_bib33","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rpth.2025.103296_bib34","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.14309\/01.ajg.0000706388.88885.06","article-title":"S1085 direct oral anticoagulants and warfarin in patients with cirrhosis and portal vein thrombosis: a comparison of outcomes","volume":"115","author":"Joseph","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rpth.2025.103296_bib35","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s10620-020-06695-4","article-title":"Safety, efficacy, and long-term outcomes of anticoagulation in cirrhotic portal vein thrombosis","volume":"66","author":"Naymagon","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rpth.2025.103296_bib36","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/liv.14992","article-title":"Safety of direct oral anticoagulants in patients with advanced liver disease","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.rpth.2025.103296_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3904\/kjim.2020.622","article-title":"Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation","volume":"37","author":"Yoo","year":"2022","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.rpth.2025.103296_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rpth.2025.103296_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.08.1889","article-title":"Use of direct acting oral anticoagulants for pulmonary embolism and DVT in patients with cirrhosis","volume":"158","author":"Naqvi","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2025.103296_bib40","first-page":"537","article-title":"Rivaroxaban versus low-molecular weight heparin plus warfarin prevents portal vein system thrombosis after splenectomy and pericardial devascularization: a randomized clinical trial","volume":"20","author":"Yao","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.rpth.2025.103296_bib41","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjmed.2019.01.006","article-title":"Anticoagulation therapy in patients with liver cirrhosis is associated with an increased risk of variceal hemorrhage","volume":"132","author":"Sasso","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2025.103296_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13074","article-title":"Safety of DOACs in patients with Child-Pugh Class C cirrhosis and atrial fibrillation","volume":"8","author":"Ayoub","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.rpth.2025.103296_bib43","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2025.103296_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.122.063195","article-title":"Use of direct-acting oral anticoagulants in patients with atrial fibrillation and chronic liver disease","volume":"147","author":"Hydes","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103296_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/17151635211058160","article-title":"The 2020 CCS atrial fibrillation guidelines for pharmacists: top 10 takeaways","volume":"155","author":"Leblanc","year":"2022","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.rpth.2025.103296_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.rpth.2025.103296_bib48","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103296_bib49","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis","volume":"161","author":"O\u2019Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpth.2025.103296_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.rpth.2025.103296_bib51","article-title":"Drug use evaluation of direct oral anticoagulants (DOACs) in patients with advanced cirrhosis","volume":"14","author":"Dadlani","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2025.103296_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40256-019-00369-x","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review","volume":"20","author":"Fu","year":"2020","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500620X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500620X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:55:25Z","timestamp":1778896525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792500620X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S247503792500620X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103296","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of direct oral anticoagulants in patients with liver cirrhosis: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103296"}}